Free Consultation

Office Locations

The Cochran Firm Legal Blog

With Office Locations Nationwide

Wednesday, May 19, 2010

Defective Weight Loss Drugs in New Orleans

The Food and Drug Administration (FDA) is reviewing safety information regarding adverse liver-related problems with the use of orlistat, which is marketed in the United States as Xenical, manufactured by Roche and Alli from GlaxoSmithKline. Xenical is available by prescription only while Alli is available over-the-counter.

There have been over thirty reports of serious liver damage and six cases of liver failure in patients using orlistat. The most common side effects reported were jaundice, weakness and abdominal pain. Other symptoms noted were nausea, vomiting, light-colored stools, itching, loss of appetite and brown urine. Patients have been advised to consult with their healthcare professionals if they are experiencing any of these symptoms with their use of orlistat.

Xenical and Alli have generated nearly $200 million in sales since 1999. Millions of people have taken Xenical and Alli believing the two were safe products that would help them lose unwanted weight, but are now finding out they may have been exposed to serious and perhaps life-threatening liver damage by these potentially defective weight loss drugs.

If you believe you or someone you care about has suffered liver damage from the use of Xenical or Alli, you may be entitled to financial compensation for your injury, medical bills, lost wages and pain and suffering. Please contact the New Orleans office of The Cochran Firm today to schedule a confidential consultation to protect your legal rights.


posted by Benjamin A. Irwin at 7:34 AM

1.800.THE FIRM | 1.800.843.3476

The Cochran Firm handles Civil Litigation and Criminal Defense claims for clients throughout the United States of America. The information on this website does not constitute legal advice nor form an attorney-client relationship.Please contact The Cochran Firm today to schedule a free consultation.

Site Design, Development and Optimization by Page 1 Solutions | © - | Disclaimer